The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost

Journal:

Science Translational Medicine

Published:

2026-02-25

DOI:

10.1126/scitranslmed.aeb9837

Affiliations:

19

Authors:

30

Go to article

Institutions	Authors	Share
NIH NIAID Vaccine Research Center (VRC), United States of America (USA)	13.833333 13.833333	0.46
University of Maryland, Baltimore (UMB), United States of America (USA)	2.000000	0.07
Baylor College of Medicine (BCM), United States of America (USA)	1.500000	0.05
NIH National Institute of Allergy and Infectious Diseases (NIAID), United States of America (USA)	1.333333	0.04
UW Medicine, United States of America (USA)	1.166667	0.04
Kaiser Permanente Washington Health Research Institute (KPWHRI), United States of America (USA)	1.000000	0.03
University of Rochester Medical Center (URMC), UR, United States of America (USA)	1.000000	0.03
Woodruff Health Sciences Center (WHSC), Emory University, United States of America (USA)	1.000000	0.03
Department of Pediatrics, Pitt, United States of America (USA)	1.000000	0.03
University of Texas Medical Branch (UTMB), United States of America (USA)	1.000000	0.03
NYU Langone Health, United States of America (USA)	1.000000	0.03
Cincinnati Children's Hospital Medical Center (CCHMC), United States of America (USA)	1.000000	0.03
NYU Langone Hospital - Long Island, United States of America (USA)	1.000000	0.03
Hope Clinic, Emory Vaccine Center, United States of America (USA)	1.000000	0.03
Fred Hutchinson Cancer Center, United States of America (USA)	0.833333	0.03
University of Oxford, United Kingdom (UK)	0.333333	0.01

Interested in Immunology?